Osaic Holdings
NXTC icon

Osaic Holdings’s NextCure NXTC Stock Holding History

Osaic Holdings’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-99
Closed -$917 – 7640
2024
Q4 		$917 Hold
99
– – ﹤0.01% 6870
2024
Q3 		$1.63K Buy
+99
New +$1.82K ﹤0.01% 6690

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings's NXTC Position: Q1 2025 in Review

Osaic Holdings sold out of NextCure (NXTC) in Q1 2025, closing a stake of 99 shares — an estimated $917 sold.

Osaic Holdings first reported a position in NXTC in Q3 2024 and held it in 2 quarters. The position peaked at $1.63K in Q3 2024. 38 funds tracked by Wall St. Rank hold NXTC as of Q1 2025.

  • Osaic Holdings reported no remaining NextCure position as of Q1 2025 after selling out during the quarter.
  • Osaic Holdings sold 99 NextCure shares in Q1 2025, an estimated $917.
  • Osaic Holdings first reported a position in NextCure in Q3 2024 and held it in 2 quarters.
  • Osaic Holdings's NextCure position peaked at $1.63K in Q3 2024.
  • 38 funds tracked by Wall St. Rank held NextCure as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.